SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-036345
Filing Date
2013-06-21
Accepted
2013-06-21 17:59:03
Documents
1
Period of Report
2013-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd384186.html 4  
1 FORM 4 rrd384186.xml 4 6311
  Complete submission text file 0001181431-13-036345.txt   7687
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 781-652-4500
CORONADO BIOSCIENCES INC (Issuer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORONADO BIOSCIENCES, INC. 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Weisman Harlan F (Reporting) CIK: 0001555563 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 13928175